Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Philippines to probe use of illegal COVID-19 vaccines

Published 02/24/2021, 03:47 PM
Updated 02/24/2021, 03:50 PM

MANILA, Feb 24 (Reuters) - The Philippines health ministry
said on Wednesday it will investigate the illegal use of
unauthorised COVID-19 vaccines, after a presidential advisor
admitted to receiving shots of a Sinopharm vaccine smuggled into
the country.
Ramon Tulfo, a celebrity radio and television host and
special envoy to China, revealed in his newspaper column on Feb.
20 and again in an interview with One News that he received a
dose in October from a batch that was also used by President
Rodrigo Duterte's security detail.
"I got hold of vaccines from a friend who smuggled it into
the country," Tulfo told One News.
News last month of Duterte's bodyguard unit taking the
vaccine, which it said was without the president's knowledge,
prompted criticism from lawmakers about privileged access and
flouting of laws.
Several government officials also received Sinopharm
1099.HK shots, Tulfo said, adding to speculation that vaccines
were available on the black market.
The Food and Drug Administration (FDA) has not approved use
of the Sinopharm vaccine, making its importation and
distribution illegal. Sinopharm has not sought emergency use
authorisation in the Philippines.
"We are investigating because it's not good to learn of
these inoculations that did not go through proper procedures,"
FDA chief Rolando Enrique Domingo said.
Philippine Health Undersecretary Rosario Vergeire said
recipients of unauthorised vaccines were also accountable.
Calls to Sinopharm in China were unanswered, and a
spokeswoman for its unit developing COVID-19 vaccines has yet to
respond to written queries.
Tulfo, 74, said he had wanted to test the vaccine's efficacy
as he was applying to be a distributor.
"I don't feel guilty about it," he said.
The Philippines has yet to start immunisations or receive
any COVID-19 vaccines that it has approved for emergency use,
despite having one of highest number of cases and deaths in
Asia.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.